Amosulalol
Amosulalol (also known as YM-09538) is a pharmaceutical drug used primarily in the treatment of hypertension and angina pectoris. It is classified as a non-selective beta blocker and alpha-1 blocker, which means it inhibits the action of certain neurotransmitters, specifically epinephrine and norepinephrine, on both beta and alpha-1 adrenergic receptors.
Pharmacology[edit]
Amosulalol works by blocking the action of epinephrine (adrenaline) and norepinephrine (noradrenaline) on the heart and blood vessels. This reduces the heart rate, decreases blood pressure, and helps to prevent angina attacks. As a non-selective beta blocker, it affects both beta-1 and beta-2 adrenergic receptors, which are found in the heart and blood vessels, as well as in other parts of the body such as the lungs. As an alpha-1 blocker, it also helps to relax the blood vessels, further reducing blood pressure.
Clinical Use[edit]
Amosulalol is used in the treatment of hypertension (high blood pressure) and angina pectoris (chest pain caused by reduced blood flow to the heart). It may also be used in the management of cardiac arrhythmias (irregular heartbeats) and in the prevention of migraine headaches.
Side Effects[edit]
Like all medications, Amosulalol can cause side effects. Common side effects include dizziness, fatigue, and nausea. Less common side effects can include bradycardia (slow heart rate), hypotension (low blood pressure), and bronchospasm (tightening of the muscles that line the airways, leading to difficulty breathing).
Contraindications[edit]
Amosulalol is contraindicated in patients with bradycardia, hypotension, severe chronic obstructive pulmonary disease (COPD), and asthma. It should also be used with caution in patients with diabetes as it can mask the symptoms of low blood sugar.
See Also[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
